These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Re: "A critical look at some popular meta-analytic methods". Olkin I Am J Epidemiol; 1994 Aug; 140(3):297-9; discussion 300-1. PubMed ID: 8048979 [No Abstract] [Full Text] [Related]
5. Meta-analysis for orthodontists: Part I--How to choose effect measure and statistical model. Papageorgiou SN J Orthod; 2014 Dec; 41(4):317-26. PubMed ID: 25404668 [TBL] [Abstract][Full Text] [Related]
6. Advances in the meta-analysis of heterogeneous clinical trials II: The quality effects model. Doi SA; Barendregt JJ; Khan S; Thalib L; Williams GM Contemp Clin Trials; 2015 Nov; 45(Pt A):123-9. PubMed ID: 26003432 [TBL] [Abstract][Full Text] [Related]
7. The statistical basis of meta-analysis. Fleiss JL Stat Methods Med Res; 1993; 2(2):121-45. PubMed ID: 8261254 [TBL] [Abstract][Full Text] [Related]
8. Meta-analyses in systematic reviews of randomized controlled trials in perinatal medicine: comparison of fixed and random effects models. Villar J; Mackey ME; Carroli G; Donner A Stat Med; 2001 Dec; 20(23):3635-47. PubMed ID: 11746343 [TBL] [Abstract][Full Text] [Related]
9. Data-generating models of dichotomous outcomes: Heterogeneity in simulation studies for a random-effects meta-analysis. Pateras K; Nikolakopoulos S; Roes K Stat Med; 2018 Mar; 37(7):1115-1124. PubMed ID: 29230852 [TBL] [Abstract][Full Text] [Related]
10. Fixed- versus random-effects models in meta-analysis: model properties and an empirical comparison of differences in results. Schmidt FL; Oh IS; Hayes TL Br J Math Stat Psychol; 2009 Feb; 62(Pt 1):97-128. PubMed ID: 18001516 [TBL] [Abstract][Full Text] [Related]
12. Meta-analysis and evidence. Goodman SN Control Clin Trials; 1989 Jun; 10(2):188-204. PubMed ID: 2666026 [TBL] [Abstract][Full Text] [Related]
13. A model for incorporating historical controls into a meta-analysis. Begg CB; Pilote L Biometrics; 1991 Sep; 47(3):899-906. PubMed ID: 1742445 [TBL] [Abstract][Full Text] [Related]
14. Meta-analysis methods for risk differences. Bonett DG; Price RM Br J Math Stat Psychol; 2014 Nov; 67(3):371-87. PubMed ID: 23962020 [TBL] [Abstract][Full Text] [Related]
15. A simplification and implementation of random-effects meta-analyses based on the exact distribution of Cochran's Q. Preuß M; Ziegler A Methods Inf Med; 2014; 53(1):54-61. PubMed ID: 24317521 [TBL] [Abstract][Full Text] [Related]
16. Overlap between treatment and control distributions as an effect size measure in experiments. Hedges LV; Olkin I Psychol Methods; 2016 Mar; 21(1):61-8. PubMed ID: 26523436 [TBL] [Abstract][Full Text] [Related]
17. The Authors Respond. Poole C; Shrier I; Ding P; VanderWeele T Epidemiology; 2016 May; 27(3):e12-3. PubMed ID: 26808604 [No Abstract] [Full Text] [Related]
18. Use of re-randomized data in meta-analysis. Hozo I; Djulbegovic B; Clark O; Lyman GH BMC Med Res Methodol; 2005 May; 5():17. PubMed ID: 15882470 [TBL] [Abstract][Full Text] [Related]
19. Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells. Rücker G; Schwarzer G; Carpenter J; Olkin I Stat Med; 2009 Feb; 28(5):721-38. PubMed ID: 19072749 [TBL] [Abstract][Full Text] [Related]
20. A Bayesian sensitivity study of risk difference in the meta-analysis of binary outcomes from sparse data. Vázquez-Polo FJ; Moreno E; Negrín MA; Martel M Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):317-22. PubMed ID: 25673174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]